BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8621918)

  • 1. T cell recognition of MHC class II-associated peptides is independent of peptide affinity for MHC and sodium dodecyl sulfate stability of the peptide/MHC complex. Effects of conservative amino acid substitutions at anchor position 1 of influenza matrix protein19-31.
    Wu S; Gorski J; Eckels DD; Newton-Nash DK
    J Immunol; 1996 May; 156(10):3815-20. PubMed ID: 8621918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of labelled influenza matrix peptide to HLA DR in living B lymphoid cells.
    Ceppellini R; Frumento G; Ferrara GB; Tosi R; Chersi A; Pernis B
    Nature; 1989 Jun; 339(6223):392-4. PubMed ID: 2786148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implication of HLA-DR residues at positions 67, 71, and 86 in interaction between HLA-DR11 and peptide HA306-320.
    Zeliszewski D; Golvano JJ; Gaudebout P; Dorval I; Freidel C; Gebuhrer L; Betuel H; Borras-Cuesta F; Sterkers G
    J Immunol; 1993 Dec; 151(11):6237-47. PubMed ID: 7504016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational and structural characteristics of peptides binding to HLA-DR molecules.
    Hill CM; Hayball JD; Allison AA; Rothbard JB
    J Immunol; 1991 Jul; 147(1):189-97. PubMed ID: 1711073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A negatively charged anchor residue promotes high affinity binding to the MHC class II molecule I-Ak.
    Nelson CA; Viner NJ; Young SP; Petzold SJ; Unanue ER
    J Immunol; 1996 Jul; 157(2):755-62. PubMed ID: 8752926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural requirements of peptide and MHC for DR(alpha, beta 1*0401)-restricted T cell antigen recognition.
    McNicholl JM; Whitworth WC; Oftung F; Fu X; Shinnick T; Jensen PE; Simon M; Wohlhueter RM; Karr RW
    J Immunol; 1995 Aug; 155(4):1951-63. PubMed ID: 7636246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes at the floor of the peptide-binding groove induce a strong preference for proline at position 3 of the bound peptide: molecular dynamics simulations of HLA-A*0217.
    Toh H; Savoie CJ; Kamikawaji N; Muta S; Sasazuki T; Kuhara S
    Biopolymers; 2000 Oct; 54(5):318-27. PubMed ID: 10935972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive alanine substitutions increase binding affinity of an influenza nucleoprotein peptide to HLA-Aw68 and do not abrogate peptide-specific CTL recognition.
    Collins EJ; Booth BL; Cerundolo V
    J Immunol; 1999 Jan; 162(1):331-7. PubMed ID: 9886403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs.
    Rudensky AYu ; Preston-Hurlburt P; al-Ramadi BK; Rothbard J; Janeway CA
    Nature; 1992 Oct; 359(6394):429-31. PubMed ID: 1328884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual effects of the DR11-variable beta-chain residues 67, 71, and 86 upon DR(alpha,beta 1*1101)-restricted, peptide-specific T cell proliferation.
    McKinney JS; Fu XT; Swearingen C; Klohe E; Karr RW
    J Immunol; 1994 Dec; 153(12):5564-71. PubMed ID: 7989758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relative importance of individual DR binding motif positions as defined by peptide anchor analysis of influenza hemagglutinin peptide 306-318 and human myelin basic protein peptide 152-165 binding to several DR molecules: definition of a common extended DR binding motif.
    Posch PE; Hastings AE; Rosen-Bronson S; Richert JR; Hurley CK
    Eur J Immunol; 1996 Aug; 26(8):1884-91. PubMed ID: 8765035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An HLA-B35-restricted epitope modified at an anchor residue results in an antagonist peptide.
    Dong T; Boyd D; Rosenberg W; Alp N; Takiguchi M; McMichael A; Rowland-Jones S
    Eur J Immunol; 1996 Feb; 26(2):335-9. PubMed ID: 8617300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2.
    Parker KC; Bednarek MA; Hull LK; Utz U; Cunningham B; Zweerink HJ; Biddison WE; Coligan JE
    J Immunol; 1992 Dec; 149(11):3580-7. PubMed ID: 1331239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pattern search method for putative anchor residues in T cell epitopes.
    Hobohm U; Meyerhans A
    Eur J Immunol; 1993 Jun; 23(6):1271-6. PubMed ID: 7684684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of peptide affinity to HLA DRB1*0401.
    Marshall KW; Wilson KJ; Liang J; Woods A; Zaller D; Rothbard JB
    J Immunol; 1995 Jun; 154(11):5927-33. PubMed ID: 7751636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.
    Newton-Nash DK; Eckels DD
    J Immunol; 1993 Mar; 150(5):1813-21. PubMed ID: 7679697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of peptide interaction with MHC creates TCR partial agonists.
    Ryan KR; McNeil LK; Dao C; Jensen PE; Evavold BD
    Cell Immunol; 2004 Jan; 227(1):70-8. PubMed ID: 15051516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
    Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
    J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of a naturally occurring HLA class I-restricted viral epitope.
    Falk K; Rötzschke O; Stevanović S; Gnau V; Sparbier K; Jung G; Rammensee HG; Walden P
    Immunology; 1994 Jul; 82(3):337-42. PubMed ID: 7525458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-peptides from four HLA-DR alleles share hydrophobic anchor residues near the NH2-terminal including proline as a stop signal for trimming.
    Kropshofer H; Max H; Halder T; Kalbus M; Muller CA; Kalbacher H
    J Immunol; 1993 Nov; 151(9):4732-42. PubMed ID: 8409432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.